Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

KIK Custom Acquires Chemtura's BioLab/Bayrol Consumer Products Business

1/2/2014 11:16 AM ET

KIK Custom Products Inc. said Thursday it completed its acquisition of the consumer products business of Chemtura Corp. (CHMT: Quote) for an adjusted purchase price of $300 million.

The company said the deal had a $15 million reduction to reflect the resolution of certain pre-closing matters by the parties. The company also said the purchase price is subject to a post-closing adjustment for working capital and assumed pension liabilities.

"This acquisition marks a major step in the strategic growth of our company," said Jeff Nodland, KIK's CEO.

Toronto, Canada-based KIK is one of North America's largest contract and private label manufacturers of consumer, institutional and industrial products. KIK entered the pool care business in 2011 with the acquisition of US-based Chem-Lab Products Inc.

Click here to receive FREE breaking news email alerts for Chemtura Corporation and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Starbucks Corp. said Thursday after the markets closed that its second quarter profit rose 9.4% from last year, helped by higher revenue. The company's quarterly earnings per share came in line with analysts' expectations, but its quarterly revenue fell short of analysts' forecast. The world's largest specialty coffee retailer also raised its full year earnings outlook. Software giant Microsoft Corp. said Thursday after the markets closed that its third quarter profit fell 6.6% from last year, when results were boosted by special upgrade offer revenues. However, the company's quarterly earnings per share came in above analysts' expectations as did its quarterly revenue. Apple Inc. said Wednesday after the markets closed that its second quarter profit rose 7% from last year, as sales surged and margins improved amid strong sales of its iPhones. The company's quarterly earnings per share also came in above analysts' expectations as did its quarterly revenue. At the same time, the company gave a slightly downbeat revenue forecast for the current quarter.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.